AAAAAA
Results:
1-24
|
Results: 24
Authors:
COUDERC R
MAACHI M
Citation: R. Couderc et M. Maachi, LIPOPROTEIN (A) - A RISK FACTOR FOR ATHER OSCLEROSIS - IMPORTANCE IN CLINICAL-PRACTICE, Journal des maladies vasculaires, 23(3), 1998, pp. 165-175
Authors:
TATE JR
RIFAI N
BERG K
COUDERC R
DATI F
KOSTNER GM
SAKURABAYASHI I
STEINMETZ A
Citation: Jr. Tate et al., INTERNATIONAL-FEDERATION-OF-CLINICAL-CHEMISTRY STANDARDIZATION PROJECT FOR THE MEASUREMENT OF LIPOPROTEIN(A) - PHASE-I - EVALUATION OF THE ANALYTICAL PERFORMANCE OF LIPOPROTEIN(A) ASSAY SYSTEMS AND COMMERCIAL CALIBRATORS, Clinical chemistry, 44(8), 1998, pp. 1629-1640
Authors:
COUDERC R
PEOCH K
VALENTI K
DIOP ME
BAILLEUL S
KIENOU L
FERRIERE F
ETIENNE J
Citation: R. Couderc et al., A SIMPLE ELECTROPHORETIC METHOD FOR PHENOTYPING APO(A) - PHENOTYPE FREQUENCY IN HEALTHY-SUBJECTS FROM PARIS, FRANCE, Clinical chemistry, 44(5), 1998, pp. 1047-1050
Authors:
BONNEAU C
COUDERC R
TISSOT M
ATHIAS A
ROCHARVEILLER M
GIROUD JP
Citation: C. Bonneau et al., EFFECTS OF HUMAN LOW-DENSITY LIPOPROTEINS ON SUPEROXIDE PRODUCTION BYFORMYL-METHIONYL-LEUCYL-PHENYLALANINE ACTIVATED POLYMORPHONUCLEAR LEUKOCYTES, European journal of clinical chemistry and clinical biochemistry, 35(2), 1997, pp. 73-80
Authors:
ANGLESCANO E
LOYAU S
KANG C
COUDERC R
VALENTI K
MULLER JH
Citation: E. Anglescano et al., A NOVEL KRINGLE-4 NUMBER-BASED RECOMBINANT APO(A) STANDARD FOR HUMAN LP(A) PHENOTYPING, Thrombosis and haemostasis, 1997, pp. 2290-2290
Authors:
ANGLESCANO E
LOYAU S
KANG C
COUDERC R
VALENTI K
MULLER JH
Citation: E. Anglescano et al., A NOVEL KRINGLE-4 NUMBER-BASED RECOMBINANT APO(A) STANDARD FOR HUMAN LP(A) PHENOTYPING, Atherosclerosis, 134(1-2), 1997, pp. 137-137
Authors:
COUDERC R
BENAMER H
GARBAZ E
JULIARD JM
CHAOUCHE S
BROCHET E
BUATOIS M
FERRIERE F
Citation: R. Couderc et al., APO(A) PHENOTYPES AND LP(A) LEVELS IN ACUTE CORONARY SYNDROMES, Atherosclerosis, 134(1-2), 1997, pp. 138-138
Authors:
LEFEVRE G
MYARA I
PEYNET J
COUDERC R
ATGER V
BAILLEUL S
BONNEAU C
CAMBILLAU M
COSSON C
DAVITSPRAUL A
ERLICH D
MARIE B
TURPIN E
Citation: G. Lefevre et al., EFFECT OF SUCROSE -80-DEGREES-C STORAGE OF PLASMA ON BETWEEN-SITE VALUES OF LOW-DENSITY-LIPOPROTEIN SUSCEPTIBILITY TO COPPER-INDUCED OXIDATION/, Clinica chimica acta, 258(2), 1997, pp. 249-255
Authors:
LEFEVRE G
BONNEAU C
RAHMA S
CHANU B
BRAULT D
COUDERC R
ETIENNE J
Citation: G. Lefevre et al., DETERMINATION OF PLASMA PROTEIN-BOUND MALONDIALDEHYDE BY DERIVATIVE SPECTROPHOTOMETRY, European journal of clinical chemistry and clinical biochemistry, 34(8), 1996, pp. 631-636
Authors:
TALLET F
VASSON MP
COUDERC R
LEFEVRE G
RAICHVARG D
Citation: F. Tallet et al., CHARACTERIZATION OF LIPOPROTEINS DURING HUMAN CHOLESTASIS, Clinica chimica acta, 244(1), 1996, pp. 1-15
Authors:
MAHIEUX F
COUDERC R
MOULIGNIER A
BAILLEUL S
PODRABINEK N
LAUDET J
Citation: F. Mahieux et al., APOLIPOPROTEIN E4 ISOFORM AND ALZHEIMERS- DISEASE, Revue neurologique, 151(4), 1995, pp. 231-239
Authors:
DENIS A
BAUDEAU C
VERDY E
COUDERC R
RONDEAU E
SRAER JD
Citation: A. Denis et al., ACQUIRED CIRCULATING ANTICOAGULANT WITH ANTI-FACTOR-V ACTIVITY IN AIDS - FIRST CASE-REPORT, Nouvelle revue francaise d'hematologie, 37(2), 1995, pp. 165-169
Authors:
BAILLEUL S
COUDERC R
ROSSIGNOL C
FERMANIAN J
BOUTOUCHENT F
FARNIER MA
ETIENNE J
Citation: S. Bailleul et al., LIPOPROTEIN(A) IN CHILDHOOD - RELATION WITH OTHER ATHEROSCLEROSIS RISK-FACTORS AND FAMILY HISTORY OF ATHEROSCLEROSIS, Clinical chemistry, 41(2), 1995, pp. 241-245
Authors:
BONNEAU C
COUDERC R
ROCHARVEILLER M
GIROUD JP
RAICHVARG D
Citation: C. Bonneau et al., EFFECTS OF LOW-DENSITY LIPOPROTEINS ON POLYMORPHONUCLEAR LEUKOCYTE FUNCTIONS IN-VITRO, Journal of lipid mediators and cell signalling, 10(3), 1994, pp. 203-212
Authors:
MAHIEUX F
COUDERC R
MOULIGNIER A
BAILLEUL S
PODRABINEK N
LAUDET J
Citation: F. Mahieux et al., APOLIPOPROTEIN E4 - PHENOTYPE IN PATIENTS WITH ALZHEIMERS-DISEASE, Annals of neurology, 35(4), 1994, pp. 506-506
Authors:
LUCOTTE G
VISVIKIS S
LEININGERMULER B
DAVID F
BERRICHE S
REVEILLEAU S
COUDERC R
BABRON MC
AGUILLON D
SIEST G
Citation: G. Lucotte et al., ASSOCIATION OF APOLIPOPROTEIN-E ALLELE EPSILON-4 WITH LATE-ONSET SPORADIC ALZHEIMERS-DISEASE, American journal of medical genetics, 54(3), 1994, pp. 286-288
Authors:
MAHIEUX F
COUDERC R
BAILLEUL S
MOULIGNIER A
Citation: F. Mahieux et al., APOLIPOPROTEIN-E EPSILON-4 ALLELE FREQUENCY IN VASCULAR DEMENTIA AND ALZHEIMERS-DISEASE - RESPONSE, Stroke, 25(8), 1994, pp. 1703-1704
Authors:
BAILLEUL S
COUDERC R
MAHIEUX F
Citation: S. Bailleul et al., APO-E PHENOTYPE IN ATHEROMATOUS PLAQUES - REPLY, Stroke, 25(11), 1994, pp. 2297-2297
Authors:
BAILLEUL S
COUDERC R
MAHIEUX F
Citation: S. Bailleul et al., APO-E PHENOTYPE IN ATHEROMATOUS PLAQUES - REPLY, Stroke, 25(11), 1994, pp. 2297-2297
Authors:
VASSON MP
ROCHARVEILLER M
COUDERC R
BAGUET JC
RAICHVARG D
Citation: Mp. Vasson et al., EFFECTS OF ALPHA-1-ACID GLYCOPROTEIN ON HUMAN POLYMORPHONUCLEAR NEUTROPHILS - INFLUENCE OF GLYCAN MICROHETEROGENEITY, Clinica chimica acta, 224(1), 1994, pp. 65-71
Authors:
LUCOTTE G
DAVID F
VISVIKIS S
LEININGERMULLER B
SIEST G
BABRON MC
COUDERC R
Citation: G. Lucotte et al., APOLIPOPROTEIN-E-SIGMA-4 ALLELE AND ALZHEIMERS-DISEASE, Lancet, 342(8882), 1993, pp. 1309-1309
Authors:
COUDERC R
MAHIEUX F
BAILLEUL S
Citation: R. Couderc et al., APOLIPOPROTEIN-E4 ALLELE FREQUENCY, ISCHEMIC CEREBROVASCULAR-DISEASE,AND ALZHEIMERS-DISEASE - REPLY, Stroke, 24(9), 1993, pp. 1416-1417
PREVALENCE OF APOLIPOPROTEIN-E PHENOTYPES IN ISCHEMIC CEREBROVASCULAR-DISEASE - A CASE-CONTROL STUDY
Authors:
COUDERC R
MAHIEUX F
BAILLEUL S
FENELON G
MARY R
FERMANIAN J
Citation: R. Couderc et al., PREVALENCE OF APOLIPOPROTEIN-E PHENOTYPES IN ISCHEMIC CEREBROVASCULAR-DISEASE - A CASE-CONTROL STUDY, Stroke, 24(5), 1993, pp. 661-664
Authors:
IDOHOU N
COUDERC R
ROCHARVEILLER M
TALLET F
GIROUD JP
RAICHVARG D
Citation: N. Idohou et al., THE IMMUNOMODULATING AGENT RU 41740 COMPLEXED WITH VERY-LOW-DENSITY LIPOPROTEINS ENHANCES HUMAN POLYMORPHONUCLEAR NEUTROPHIL OXIDATIVE-METABOLISM INVITRO, Pharmacology, 46(6), 1993, pp. 341-345
Risultati:
1-24
|